A multicenter phase II study of belotecan, a new camptothecin analogue, in elderly patients with previously untreated, extensive-stage small cell lung cancer

By Yeo Chang   Lee Sang   Kim Ju   Kim Seung   Kim Seok   Kim Young   Kang Hyeon   Yoon Hyung   Song Jeong   Moon Hwa   Kim Jin   Kim Kwan   Shim Byoung   Kim Chi  

Cancer Chemotherapy and Pharmacology, Vol. 72, Iss. 4, 2013-10 ,pp. : 809-814

Springer Publishing Company

Access to resources Recommend Favorite

Phase II Study of Infusional Cisplatin in Combination with Etoposide in the Treatment of Small Cell Lung Cancer

By Mori K.   Ohta S.   Kishiro I.   Yokoyama K.   Suga Y.   Tominaga K.  

European Journal of Cancer, Vol. 31, Iss. 11, 1995-10 ,pp. : 1781-1784

Elsevier

Access to resources Recommend Favorite

A phase II study of dose-intensified weekly concomitant administration of cisplatin and irinotecan in chemonaive patients with extensive-disease small-cell lung cancer

By Han Ji-Youn   Lee Dae   Lee Sung   Park Chun   Kim Hae   Kim Eun-A   Yoon Sung   Lee Hong   Lee Jin  

Medical Oncology, Vol. 22, Iss. 3, 2005-09 ,pp. : 281-290

Humana Press, Inc

Access to resources Recommend Favorite

A multi-institutional phase II study of combination chemotherapy with S-1 plus cisplatin in patients with advanced non-small cell lung cancer

By                                  

Oncology Letters, Vol. 2, Iss. 3, 2011-01 ,pp. : 465-470

Spandidos Publications

Access to resources Recommend Favorite

A Phase I Trial Defining the Maximum Tolerated Systemic Exposure of Topotecan in Combination with Carboplatin and Etoposide in Extensive Stage Small Cell Lung Cancer

By Gillenwater Heidi   McCune Jeannine   Lindley Celeste   Faucette Stephanie   Shord Stacy   Donahue Angela   Socinski Mark   Stewart Clinton   Zamboni William   Kirstein Mark   Moore Dominic  

Cancer Investigation, Vol. 23, Iss. 6, 2005-09 ,pp. : 511-519

Informa Healthcare

Access to resources Recommend Favorite